Mr. Sander has 29 years of extensive experience in the surgical products industry focusing on research, product development and technology development. He has worked in various roles for such industry leaders as U.S. Surgical Corporation, Pfizer (Howmedica-Leibinger), Regeneration Technologies, and Smith & Nephew. Most recently Mr. Sander was a co-founder of Pegasus Biologics, Inc. which successfully commercialized a collagen scaffold made from equine pericardium. He has an established track record for advancing cutting edge technologies in resorbable polymer and tissue-based research. In these roles he has directed high-level R&D teams in surgical product design, development, and marketing. In addition he has assisted in the successful development of preclinical and clinical test protocols. More recently he has led the commercialization of new bioengineered technologies, including bioresorbable bone fixation devices, precision-machined human bone allografts, and biologic tissue scaffolds.

Mr. Sander has earned an undergraduate engineering degree from Clemson University and a Masters Degree in Bioengineering from Tulane University.

Mr. Sander partners with client companies in the areas of:

• Providing R&D expertise in many areas of musculoskeletal repair
  • Orthopedics
    
  • ENT
    
  • Sports Medicine
    
  • Podiatry
    
  • Craniomaxillofacial
    
  • Extremities
    
  
  
• Bioresorbable polymer technology
  
  
• Development of tissue-based (xenograft/allograft) biologic devices
  
  
• Development of functional preclinical studies
  
  
• Strategic regulatory planning
  
  
• Strategic planning for the efficient drive towards commercialization of surgical products
  
  
• Providing expert legal opinions
  
  
• Assessing and driving technology development towards successful business start-ups